Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jul 6;14:1224892. doi: 10.3389/fimmu.2023.1224892

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 Song, Lian and Zhang

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

The structure of AP-1 inhibitors. (A) T-5224: Reuse from MedChemExpress, CAT: HY-12270, CAS NO.: 530141-72-1. (B) SP600125: Reuse from MedChemExpress, CAT: HY-12041, CAS NO.: 129-56-6. (C) Doxycycline: Reuse from MedChemExpress, CAT: HY-N0565, CAS NO.: 5564-25-0. (D) SR11302: Reuse from MedChemExpress, CAT: HY-15870, CAS NO.: 160162-42-5. (E) SPC839: Reuse from MedChemExpress, CAT: HY-10072, CAS NO.: 219773-55-4. (F) (+)-Glaucarubinone: Reuse from MedChemExpress, CAT: HY-N10926, CAS NO.: 11259-86-5. (G) XR5944: Reuse from Br J Cancer 2007, 97(7): 844-850. Verborg W et al., First-into-man phase I and pharmacokinetic study of XR5944.14, a novel agent with a unique mechanism of action (71). Copyright 2007 is provided under the terms of the Creative Commons CC BY License (http://creativecommons.org/licenses/by/4.0).